Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men
- PMID: 20038741
- DOI: 10.1161/CIRCULATIONAHA.109.887521
Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men
Abstract
Background: The purpose of this study was to investigate associations between combinations of body mass index (BMI) categories and metabolic syndrome (MetS) and the risk of cardiovascular disease and death in middle-aged men.
Methods and results: At age 50 years, cardiovascular risk factors were assessed in 1758 participants without diabetes in the community-based Uppsala Longitudinal Study of Adult Men (ULSAM). According to BMI-MetS status, they were categorized as normal weight (BMI <25 kg/m(2)) without MetS (National Cholesterol Education Program criteria; n=891), normal weight with MetS (n=64), overweight (BMI 25 to 30 kg/m(2)) without MetS (n=582), overweight with MetS (n=125), obese (BMI >30 kg/m(2)) without MetS (n=30), or obese with MetS (n=66). During follow-up (median 30 years), 788 participants died, and 681 developed cardiovascular disease (composite of cardiovascular death or hospitalization for myocardial infarction, stroke, or heart failure). In Cox proportional-hazards models that adjusted for age, smoking, and low-density lipoprotein cholesterol, an increased risk for cardiovascular disease was observed in normal-weight participants with MetS (hazard ratio 1.63, 95% confidence interval 1.11 to 2.37), overweight participants without MetS (hazard ratio 1.52, 95% confidence interval 1.28 to 1.80), overweight participants with MetS (hazard ratio 1.74, 95% confidence interval 1.32 to 2.30), obese participants without MetS (hazard ratio 1.95, 95% confidence interval 1.14 to 3.34), and obese participants with MetS (hazard ratio 2.55, 95% confidence interval 1.81 to 3.58) compared with normal-weight individuals without MetS. These BMI-MetS categories significantly predicted total mortality rate in a similar pattern.
Conclusions: Middle-aged men with MetS had increased risk for cardiovascular events and total death regardless of BMI status during more than 30 years of follow-up. In contrast to previous reports, overweight and obese individuals without MetS also had an increased risk. The present data refute the notion that overweight and obesity without MetS are benign conditions.
Comment in
-
Letter by McAuley et al regarding article, "Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men".Circulation. 2010 Sep 14;122(11):e455; author reply e457. doi: 10.1161/CIRCULATIONAHA.110.942094. Circulation. 2010. PMID: 20837934 No abstract available.
-
Letter by Stefan et al regarding article, "Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men".Circulation. 2010 Sep 14;122(11):e456; author reply e457. doi: 10.1161/CIRCULATIONAHA.110.942276. Circulation. 2010. PMID: 20837935 No abstract available.
Similar articles
-
Metabolic and lifestyle predictors of ischemic heart disease and all-cause mortality among normal weight, overweight, and obese men: a 16-year follow-up in the Copenhagen Male Study.Metab Syndr Relat Disord. 2009 Apr;7(2):97-104. doi: 10.1089/met.2008.0041. Metab Syndr Relat Disord. 2009. PMID: 19032035
-
Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes.Arch Intern Med. 2005 Oct 10;165(18):2114-20. doi: 10.1001/archinte.165.18.2114. Arch Intern Med. 2005. PMID: 16217001
-
Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals.Circulation. 2007 Jul 24;116(4):375-84. doi: 10.1161/CIRCULATIONAHA.107.688788. Epub 2007 Jul 9. Circulation. 2007. PMID: 17620505
-
Metabolic syndrome in Cushing's syndrome.Neuroendocrinology. 2010;92 Suppl 1:96-101. doi: 10.1159/000314272. Epub 2010 Sep 10. Neuroendocrinology. 2010. PMID: 20829627 Review.
-
Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies.Int J Cardiol. 2013 Oct 12;168(5):4761-8. doi: 10.1016/j.ijcard.2013.07.230. Epub 2013 Aug 1. Int J Cardiol. 2013. PMID: 23972953 Review.
Cited by
-
Blood pool activity on F-18 FDG PET/CT as a possible imaging biomarker of metabolic syndrome.Sci Rep. 2020 Oct 15;10(1):17367. doi: 10.1038/s41598-020-74443-9. Sci Rep. 2020. PMID: 33060688 Free PMC article.
-
Metabolically healthy obesity and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a protocol for a systematic review and meta-analysis of prospective studies.BMJ Open. 2019 Oct 28;9(10):e032742. doi: 10.1136/bmjopen-2019-032742. BMJ Open. 2019. PMID: 31662402 Free PMC article.
-
The Complex Interactions Between Obesity, Metabolism and the Brain.Front Neurosci. 2019 May 24;13:513. doi: 10.3389/fnins.2019.00513. eCollection 2019. Front Neurosci. 2019. PMID: 31178685 Free PMC article. Review.
-
Metabolically Healthy Obesity-Heterogeneity in Definitions and Unconventional Factors.Metabolites. 2020 Jan 27;10(2):48. doi: 10.3390/metabo10020048. Metabolites. 2020. PMID: 32012784 Free PMC article. Review.
-
The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults.Diabetes Metab J. 2019 Dec;43(6):867-878. doi: 10.4093/dmj.2018.0130. Epub 2019 Apr 3. Diabetes Metab J. 2019. PMID: 30968620 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical